However, the S100B-mediated inflammatory inhibitors exert neuroprotective effects against cerebral I/R injury by reducing oxidative stress and suppressing the inflammatory response after transient cerebral ischemia [35], [36]. The gene discussed is S100B; the disease is transient ischemic attack.